InvestorsHub Logo
Followers 1
Posts 205
Boards Moderated 0
Alias Born 04/23/2012

Re: mainebuys post# 5728

Friday, 02/22/2013 8:55:05 PM

Friday, February 22, 2013 8:55:05 PM

Post# of 32544
I'm assuming PSID licensed Iglucose to SGMC..

As that's the only one of PSID's glucose related products, that are, currently, FDA approved, at this time, to my knowledge..

If PSID can fast track their EASY CHECK blood glucose breath testing meter to get FDA approved, licensed, manufactured, and bring to market with reliable sellers, before any of their competition does..

Assuming if PSID's EASY CHECK comes to market, within a reasonable period of time, and is the only provider of this technology, without having any competiton world wide..



If PSID had beat their Competitors to market ~ our share price would have been rewarded, accordingly, a long time ago..

IMO, PositiveID should have been more on the ball and gotten their two individual diabetes testing devices developed before their competition did..

1. PSID's GlucoMeter, hasn't even been FDA approved, yet..

2. And PSID's Iglucose device system, even though it was FDA approved.. Should have been licensed, manufacured and marketed for sales by reliable sellers, a long time ago, to generate revenue and increase share holder value..

PSID's two Competitors, IDEAL LIFE, and TELCARE are getting richer than rich, selling their own diabetes devices, like hot cakes..

IDEAl LIFE has been selling their own blood glucose device communications portal version, very similar to PositiveID's Iglucose device, for quite some time, now..

And PositiveID hasn' event sold any Iglucose device sytems, yet, to my knowledge..

TELCARE has been selling their own Blood Glucose Meter Testing Device, an all in one unit, that has a invasive blood glucose testing meter and a communication device combined, together, which is quite similar to PSID's GlucoMeter Device..

It's really too bad, for everyone concerned, that PSID wasn't able to beat out their Competiton and increase PSID share holder value, as we were expecting, when they had a chance to do so, on a timely manner..

Let's all hope for the best concerning PSID's BioWatch Generation 3 endeavor, that we're anticipating to increase share holder value, if PSID wins the stage 2 testin, Final Request For Proposal Contract..

And DHS decides to fully implement and deploy all 2500 units, as was proposed, during the next 5 years..

greaseyfingers Thursday, February 21, 2013 8:48:27 AM
Re: Peace-maker post# 5608 Post #5613 of 5664

PSID makes Iglucose, the GlucoMeter, and EasyCheck..

They are three individual, seperate PSID devices and function differently..

Iglucose is the communication portal device that works with certain blood glucose testing meters, that are compatable..

The PSID GlucoMeter is an all in one unit, that has a invasive blood glucose testing meter and communication device combined, together, like the one Telcare is already selling, a PSID Competitor..

EasyCheck is a Non-Invasive blood glucose breath testing meter, that if once approved, could be used with the Iglucose communication portal device..

Of these three individual PSID devices, as mentioned, to my knowledge, Iglucose is the only one that has been FDA approved, so far..

If you go to PSID's website you can read more about them in more detail, if you're interested in doing so..

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=84834494

mainebuys Friday, February 22, 2013 7:16:51 PM
Re: greaseyfingers post# 5726 Post #5728 of 5728

I am not often proven wrong. Very nice job of researching subject matter. Your related post on this subject should have reflected this degree of accuracy. So in your opinion what did they license to SGMC. IT is beyond me why they are making a GLUCCOMETER. This technology will soon be rendered obsolete, when EASYCHECK is released.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=84919910

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.